2019
DOI: 10.1208/s12249-019-1554-1
|View full text |Cite
|
Sign up to set email alerts
|

The Influence of Matrix Technology on the Subdivision of Sustained Release Matrix Tablets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 28 publications
0
9
0
Order By: Relevance
“…Tablets for controlled release purposes and orally disintegrating tablets might lose predesigned properties when subdivided. [4][5][6] In addition, tablet subdivision might result in two halves that are different in weight and in the corresponding amount of active ingredient. [7][8][9] This can have a serious consequence for potent drugs with a narrow therapeutic index.…”
Section: Introductionmentioning
confidence: 99%
“…Tablets for controlled release purposes and orally disintegrating tablets might lose predesigned properties when subdivided. [4][5][6] In addition, tablet subdivision might result in two halves that are different in weight and in the corresponding amount of active ingredient. [7][8][9] This can have a serious consequence for potent drugs with a narrow therapeutic index.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, studies conducted with different types of matrices have demonstrated that in the case of tablets that preserve their shape for a longer period of time along with the dissolution (such as inert and lipid matrices), the drug diffusion mechanism is decisively influenced by the surface area of the dosage form [16,17]. Hence, the cross-section of the tablet caused by the subdivision gives rise to a new surface, leading to dissolution rate variations of up to 20%, an unacceptable range for a narrow therapeutic window drug such as clomipramine tablets [15].…”
Section: How the Tablet Subdivision Could Affect Different Technologiesmentioning
confidence: 99%
“…In other cases, tablet subdivision has been encouraged and is commonly recommended by manufacturers. Recent studies conducted by our research group and others, however, identify previously ignored problems arising from this practice [11][12][13][14][15]. The scenario becomes even more complicated with the advancement of drug-release technologies employing new materials and processes.…”
mentioning
confidence: 95%
“…However, in some studies conducted by different researchers such as Chou et al (2015) reported that unequal tablet splitting causes inaccurate dose titration and even result in toxicity. Another researcher also reported that the subdivision of tablets containing inert matrices greatly affects the kinetic release profile (Teixeira et al, 2020). In another study, the effect of splitting on levothyroxine has been discussed.…”
Section: Introductionmentioning
confidence: 99%